The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins
- PMID: 15249583
- PMCID: PMC2172316
- DOI: 10.1083/jcb.200403069
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins
Abstract
Insulin-like growth factors elicit many responses through activation of phosphoinositide 3-OH kinase (PI3K). The tuberous sclerosis complex (TSC1-2) suppresses cell growth by negatively regulating a protein kinase, p70S6K (S6K1), which generally requires PI3K signals for its activation. Here, we show that TSC1-2 is required for insulin signaling to PI3K. TSC1-2 maintains insulin signaling to PI3K by restraining the activity of S6K, which when activated inactivates insulin receptor substrate (IRS) function, via repression of IRS-1 gene expression and via direct phosphorylation of IRS-1. Our results argue that the low malignant potential of tumors arising from TSC1-2 dysfunction may be explained by the failure of TSC mutant cells to activate PI3K and its downstream effectors.
Copyright The Rockerfeller University Press
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2172316/bin/200403069f1.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2172316/bin/200403069f2.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2172316/bin/200403069f3ac.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2172316/bin/200403069f3ac.gif)
![Figure 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2172316/bin/200403069f4ad.gif)
![Figure 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2172316/bin/200403069f4ad.gif)
![Figure 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2172316/bin/200403069f5ad.gif)
![Figure 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2172316/bin/200403069f5ad.gif)
![Figure 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2172316/bin/200403069f6ad.gif)
![Figure 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2172316/bin/200403069f6ad.gif)
![Figure 7.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2172316/bin/200403069f7ab.gif)
![Figure 7.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2172316/bin/200403069f7ab.gif)
![Figure 8.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2172316/bin/200403069f8.gif)
Similar articles
-
Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.J Cell Biol. 2002 Oct 28;159(2):217-24. doi: 10.1083/jcb.jcb.200206108. Epub 2002 Oct 28. J Cell Biol. 2002. PMID: 12403809 Free PMC article.
-
Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies.Curr Biol. 2004 Sep 21;14(18):1650-6. doi: 10.1016/j.cub.2004.08.026. Curr Biol. 2004. PMID: 15380067
-
Insulin signaling during perinatal liver development in the rat.Am J Physiol Endocrinol Metab. 2002 Oct;283(4):E844-52. doi: 10.1152/ajpendo.00111.2002. Am J Physiol Endocrinol Metab. 2002. PMID: 12217903
-
The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.Novartis Found Symp. 2004;262:148-54; discussion 154-9, 265-8. Novartis Found Symp. 2004. PMID: 15562827 Review.
-
Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis.Cell Cycle. 2007 Mar 15;6(6):631-7. doi: 10.4161/cc.6.6.3987. Epub 2007 Mar 7. Cell Cycle. 2007. PMID: 17361103 Review.
Cited by
-
An estrogen receptor α-derived peptide improves glucose homeostasis during obesity.Nat Commun. 2024 Apr 22;15(1):3410. doi: 10.1038/s41467-024-47687-6. Nat Commun. 2024. PMID: 38649684 Free PMC article.
-
Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets.Cells. 2024 Feb 27;13(5):409. doi: 10.3390/cells13050409. Cells. 2024. PMID: 38474373 Free PMC article. Review.
-
Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer.Br J Cancer. 2024 May;130(8):1377-1387. doi: 10.1038/s41416-024-02614-w. Epub 2024 Feb 23. Br J Cancer. 2024. PMID: 38396173 Free PMC article.
-
The mTORC2 signaling network: targets and cross-talks.Biochem J. 2024 Jan 25;481(2):45-91. doi: 10.1042/BCJ20220325. Biochem J. 2024. PMID: 38270460 Free PMC article. Review.
-
Diabetic sensory neuropathy and insulin resistance are induced by loss of UCHL1 in Drosophila.Nat Commun. 2024 Jan 11;15(1):468. doi: 10.1038/s41467-024-44747-9. Nat Commun. 2024. PMID: 38212312 Free PMC article.
References
-
- Brown, E.J., P.A. Beal, C.T. Keith, J. Chen, T.B. Shin, and S.L. Schreiber. 1995. Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature. 377:441–446. - PubMed
-
- Cantley, L.C. 2002. The phosphoinositide 3-kinase pathway. Science. 296:1655–1657. - PubMed
-
- Crackower, M.A., G.Y. Oudit, I. Kozieradzki, R. Sarao, H. Sun, T. Sasaki, E. Hirsch, A. Suzuki, T. Shioi, J. Irie-Sasaki, et al. 2002. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell. 110:737–749. - PubMed
-
- de Groot, R.P., L.M. Ballou, and P. Sassone-Corsi. 1994. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternative route to mitogen-induced gene expression. Cell. 79:81–91. - PubMed
-
- Dufner, A., and G. Thomas. 1999. Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253:100–109. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases